{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:36:05Z","timestamp":1790825765099,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012775","name":"Royal Melbourne Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019944","name":"Sanofi-Aventis Deutschland GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001064","name":"Epilepsy Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012504","name":"Royal Melbourne Hospital Neuroscience Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.yebeh.2025.110663","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T22:36:45Z","timestamp":1756420605000},"page":"110663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Balancing foetal disadvantage and seizure freedom in women capable of pregnancy \u2013 the Australian pregnancy register experience"],"prefix":"10.1016","volume":"172","author":[{"given":"Frank","family":"Vajda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-8621","authenticated-orcid":false,"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-2351","authenticated-orcid":false,"given":"Janet","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-7066","authenticated-orcid":false,"given":"Piero","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2025.110663_b0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1528-1167.2009.02128.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110663_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","article-title":"Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy","volume":"29","author":"Reisinger","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110663_b0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/ane.13609","article-title":"Epileptic seizure control during and after pregnancy in Australian women","volume":"145","author":"Vajda","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110663_b0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(86)80949-0","article-title":"Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid","volume":"108","author":"J\u00e4ger-Roman","year":"1986","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110663_b0025","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ajmg.a.35438","article-title":"Antiepileptic drugs and pregnancy outcomes","volume":"158A","author":"Wlodarczyk","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110663_b0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"16","key":"10.1016\/j.yebeh.2025.110663_b0035","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2025.110663_b0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.seizure.2016.10.006","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes","volume":"44","author":"Bromley","year":"2017","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110663_b0045","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110663_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110663_b0055","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jocn.2010.05.008","article-title":"The Australian pregnancy register of anti-epileptic drugs: 10 years of progress","volume":"17","author":"Vajda","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2025.110663_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/epi.18335","article-title":"Assisted reproduction and the fetal malformation risk associated with antiseizure medication exposure in pregnancy","author":"Vajda","year":"2025","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110663_b0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1440-1754.1998.00208.x","article-title":"Congenital malformations in Victoria, Australia, 1983-95: an overview of infant characteristics","volume":"34","author":"Riley","year":"1998","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110663_b0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"10.1016\/j.yebeh.2025.110663_b0075","unstructured":"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-31-august-2023."},{"key":"10.1016\/j.yebeh.2025.110663_b0080","unstructured":"https:\/\/www.gov.uk\/drug-safety-update\/topiramate-topamax-introduction-of-new-safety-measures-including-a-pregnancy-prevention-programme."},{"issue":"3","key":"10.1016\/j.yebeh.2025.110663_b0085","first-page":"e27","article-title":"Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: does effectiveness offset the teratogenic risks?","volume":"65","author":"Cerulli Irelli","year":"2024","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110663_b0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal exposure to antiseizure medication and incidence of childhood- and adolescence-onset psychiatric disorders","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110663_b0095","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209448","article-title":"Association of prenatal exposure to antiseizure medications with creative and executive function at age 4.5 years","volume":"102","author":"Meador","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110663_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2024.3982","article-title":"Neuropsychological outcomes in 6-year-old children of women with epilepsy: a prospective nonrandomized clinical Trial","volume":"82","author":"Meador","year":"2025","journal-title":"JAMA Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:32:14Z","timestamp":1780299134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025004032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":20,"alternative-id":["S1525505025004032"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110663","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing foetal disadvantage and seizure freedom in women capable of pregnancy \u2013 the Australian pregnancy register experience","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110663"}}